171 related articles for article (PubMed ID: 3013261)
1. [Hypercoagulability and cerebral infarction].
Matsuda T
No To Shinkei; 1986 Apr; 38(4):317-27. PubMed ID: 3013261
[No Abstract] [Full Text] [Related]
2. Antiplatelet therapy.
Sloan RW
Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
[TBL] [Abstract][Full Text] [Related]
3. [Blood platelets and myocardial infarction].
Musiał J; Dworski R; Szczeklik A
Pol Tyg Lek; 1984 Dec; 39(50):1665-8. PubMed ID: 6396594
[No Abstract] [Full Text] [Related]
4. [Role of antiplatelet agents in the prevention of cerebral ischemic accidents].
Bousser MG
J Mal Vasc; 1983; 8(1):17-22. PubMed ID: 6341494
[TBL] [Abstract][Full Text] [Related]
5. Platelet function inhibitors: their clinical use.
Fuster V; Didisheim P
Adv Intern Med; 1978; 23():251-64. PubMed ID: 343540
[No Abstract] [Full Text] [Related]
6. [Therapy with anticoagulants and platelet aggregation inhibitors in extracranial vascular stenoses and occlusions].
Ostendorf P
Internist (Berl); 1979 Nov; 20(11):539-46. PubMed ID: 396265
[No Abstract] [Full Text] [Related]
7. [Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review].
Verdecchia P
G Ital Cardiol; 1982; 12(8):598-603. PubMed ID: 6762978
[No Abstract] [Full Text] [Related]
8. Role of platelet-active drugs in coronary artery disease.
Sherry S
Cardiovasc Clin; 1983; 14(1):173-89. PubMed ID: 6352025
[No Abstract] [Full Text] [Related]
9. Radioimmunoassay of serum thromboxane B2: a simple method of assessing pharmacologic effects on platelet function.
Patrono C; Ciabattoni G; Pugliese F; Pinca E; Castrucci G; De Salvo A; Satta MA; Parachini M
Adv Prostaglandin Thromboxane Res; 1980; 6():187-91. PubMed ID: 7386257
[No Abstract] [Full Text] [Related]
10. Aspirin and other platelet-aggregation inhibiting drugs.
Gallus AS
Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
[TBL] [Abstract][Full Text] [Related]
11. A critical appraisal of the clinical efficiency of anti-platelet drugs.
Lecompte T; Samama M
Agents Actions Suppl; 1986; 20():203-14. PubMed ID: 3544741
[No Abstract] [Full Text] [Related]
12. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
Sherry S
Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782
[No Abstract] [Full Text] [Related]
13. [Thrombosis prevention with thrombocyte aggregation inhibitors in the venous system].
Schöndorf TH
Med Welt; 1982 Jun; 33(23):851-4. PubMed ID: 7050615
[No Abstract] [Full Text] [Related]
14. Mode of action of currently used antiplatelet drugs.
de Gaetano G; Bertele' V; Cerletti C
Agents Actions Suppl; 1986; 20():191-201. PubMed ID: 3101442
[No Abstract] [Full Text] [Related]
15. Antiplatelet drugs in the management of patients with thrombotic disorders.
Harker LA
Semin Thromb Hemost; 1986 Apr; 12(2):134-55. PubMed ID: 3016905
[No Abstract] [Full Text] [Related]
16. Platelet aggregation and atherosclerosis.
Valladares BK; Lemberg L
Heart Lung; 1986 Mar; 15(2):211-4. PubMed ID: 3633253
[TBL] [Abstract][Full Text] [Related]
17. Platelets and prostaglandins in sudden death: therapeutic implications.
Gelman JS; Mehta J
Cardiovasc Clin; 1985; 15(3):65-80. PubMed ID: 2870807
[No Abstract] [Full Text] [Related]
18. Effect of drugs of platelets and complications of vascular disease.
Mustard JF; Packham MA; Kinlough-Rathbone RL
Adv Exp Med Biol; 1977; 82():94-105. PubMed ID: 920448
[No Abstract] [Full Text] [Related]
19. [Clinical application and evaluation of anti-platelet agents].
Yasunaga K
Nihon Rinsho; 1978 Dec; 36(12):3884-94. PubMed ID: 372628
[No Abstract] [Full Text] [Related]
20. [Current clinical results of antiplatelet medication].
Ordinas A
Sangre (Barc); 1984; 29(4-C):833-40. PubMed ID: 6393391
[No Abstract] [Full Text] [Related]
[Next] [New Search]